Friday 23 October · 23:03
13°C Amsterdam
AEX1131.63▼0.9%ASML1407.20▼5.9%ING28.46▼3.5%PHILIPS24.08▲5.1%UNILEVER59.02▲1.4%AEX1131.63▼0.9%ASML1407.20▼5.9%ING28.46▼3.5%PHILIPS24.08▲5.1%UNILEVER59.02▲1.4%

Iconic RPG Developer BioWare Shuts Down After 31 Years

Tech·22 Oct 2026·ExpatDaily Editorial·3 min read
Share
Iconic RPG Developer BioWare Shuts Down After 31 Years
Photo: Unsplash

The gaming world is reeling after the announcement that BioWare, the studio responsible for defining the modern role playing game, is ceasing operations. Founded in 1995, the Canadian developer became a household name for its narrative depth and complex player choice mechanics. However, parent company Electronic Arts confirmed the studio will shut down, marking the end of an era for the industry.

BioWare first rose to international prominence with the 1998 release of Baldur's Gate, which successfully adapted the Dungeons and Dragons tabletop experience for personal computers. Throughout the early 2000s, the company cemented its reputation with legendary titles like Star Wars: Knights of the Old Republic and the Dragon Age fantasy series. These games set a standard for storytelling that many developers still strive to reach today.

The Legacy of Mass Effect

The Mass Effect trilogy remains arguably the studio's greatest achievement. The series was celebrated for its intricate dialogue trees and the lasting consequences of player decisions, which often determined the fates of entire civilizations or individual crew members. It was truly revolutionary, allowing players to navigate complex social relationships and moral dilemmas that felt deeply personal.

Despite this pedigree, the studio struggled in recent years. Commercial disappointments like Mass Effect: Andromeda and the service game Anthem weakened the studio's standing within Electronic Arts. According to company executives, recent sales figures for Dragon Age: The Veilguard failed to meet internal targets, ultimately leading to this final decision to liquidate the studio.

Our games gained so much more meaning because you played them, discussed your choices, fell in love with our characters, and made our worlds your own.

In a poignant farewell statement, the team thanked their global community for being the primary component of their journey over the last three decades. The cancellation also means that the much anticipated next installment in the Mass Effect series has been officially scrapped. This move comes as part of a wider trend of consolidation in the Tech sector.

A Global Corporate Shift

The closure follows the high profile acquisition of Electronic Arts by a Saudi investment group. The deal, valued at 55 billion dollars, has left the publisher under significant pressure to manage debt and streamline operations. As part of this consolidation, EA has indicated it will move away from developing multiple large scale action adventure titles simultaneously to control costs.

For expats and international workers living in the Netherlands, this news highlights the volatility of the global tech sector. If you are employed in the gaming or software industry, such shifts can lead to sudden changes in job security, tax implications regarding severance, or even shifting visa requirements if your employment contract is tied to a specific project or parent company. It serves as a reminder to always maintain a clear view of your legal rights and local labor protections.

While the closure of BioWare represents a significant loss for creative game development, the industry continues to evolve under new ownership models. EA maintains that while BioWare is gone, they remain committed to producing upcoming titles like Star Wars and Iron Man projects. The loss of such a foundational studio, however, will be felt by fans who grew up alongside the characters and worlds BioWare built.

Share
Original report: NOS·View source ↗·Our sources

In other news

Breakthrough Treatment Significantly Reduces Melanoma Recurrence
Tech
Breakthrough Treatment Significantly Reduces Melanoma Recurrence

A promising new therapeutic injection developed by Moderna and Merck has shown a 42 percent reduction in the risk of death or cancer recurrence in melanoma patients. The treatment, which complements standard immunotherapy, was recently highlighted at a major oncology conference.

NOS·18h ago